![The kick that didn't kill: first-ever randomised HIV cure study fails to eliminate infected cells | aidsmap The kick that didn't kill: first-ever randomised HIV cure study fails to eliminate infected cells | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_social_default/public/2018-07/the-kick-that-didn%E2%80%99t-kill-first-ever-randomised-hiv-cure-study-fails-to-eliminate-infected-cells.jpg?itok=y6v69WPj)
The kick that didn't kill: first-ever randomised HIV cure study fails to eliminate infected cells | aidsmap
![Uganda HIV/AIDS Legal Environment Assessment for Key Populations Report Launch | Friday, September 2, 2022 - U.S. Embassy in Uganda Uganda HIV/AIDS Legal Environment Assessment for Key Populations Report Launch | Friday, September 2, 2022 - U.S. Embassy in Uganda](https://ug.usembassy.gov/wp-content/uploads/sites/42/IMG_1571.amb_.listening-350x196.jpg)
Uganda HIV/AIDS Legal Environment Assessment for Key Populations Report Launch | Friday, September 2, 2022 - U.S. Embassy in Uganda
![Interaction between antiretroviral boosters and corticosteroids can lead to development of Cushing's syndrome | aidsmap Interaction between antiretroviral boosters and corticosteroids can lead to development of Cushing's syndrome | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_medium_crop/public/2019-09/treatment%20%281%29.png?itok=9Vp8nfsG)
Interaction between antiretroviral boosters and corticosteroids can lead to development of Cushing's syndrome | aidsmap
![High Rates of PrEP Adherence and Persistence for F/TAF Patients - Infectious Disease Special Edition High Rates of PrEP Adherence and Persistence for F/TAF Patients - Infectious Disease Special Edition](https://www.idse.net/aimages/2022/Descovy_lead.jpg)